Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 4Cohance Lifesciences
02 2Strides Pharma Science
03 1ABRAXIS PHARM
04 5Abbott Laboratories
05 11Actavis Inc
06 2Amneal Pharmaceuticals
07 1Amphastar Pharmaceuticals
08 3Apotex Fermentation Inc.
09 2Apotex Inc
10 1Aurobindo Pharma Limited
11 4Avet Pharmaceuticals
12 7Azurity Pharma
13 1BEDFORD LABS
14 1BGP PHARMA ULC
15 2Caplin Point Laboratories Limited
16 3Chartwell Pharmaceuticals llc
17 2Exela Pharma Sciences, LLC.
18 4Farbe Firma
19 1Fresenius Kabi USA
20 1GD Searle LLC
21 1GLAND PHARMA LIMITED
22 3Glenmark Pharmaceuticals
23 7Hospira, Inc.
24 3IVAX Pharmaceuticals Inc
25 2Luitpold Pharmaceuticals, Inc.
26 2MARSAM PHARMS LLC
27 4MT ADAMS
28 1Mankind Pharma
29 2Micro Labs Limited
30 2Mutual Pharmaceutical Company, Inc.
31 2Nephron Pharmaceuticals Corporation
32 9Pfizer Inc
33 1Pharmascience Inc.
34 4Pliva Hrvatska
35 1Pluviaendo
36 1Quad Pharma
37 8Rising Pharmaceuticals Inc
38 2SMITH & NEPHEW INC
39 2Sandoz B2B
40 1Smith & Kenner Pharmaceuticals
41 1Solo Pak
42 4Somerset Pharmaceuticals Inc
43 5Sun Pharmaceutical Industries Limited
44 18Viatris
45 2Warner Chilcott Company, LLC
46 3Zydus Lifesciences
47 1Zydus Pharmaceuticals
01 13CAPSULE, EXTENDED RELEASE;ORAL
02 2Film Coated Tablet
03 3Filmtabl
04 21INJECTABLE;INJECTION
05 1INJEKTIONSVÄTSKA, LÖSNING
06 1Injectable; Injection
07 4Injection
08 1LIQUID
09 5Ret Filmtabl
10 18SOLUTION;INTRAVENOUS
11 1SRC
12 1SRT
13 4Sustain Release Capsule
14 4TAB
15 2TABLET
16 5TABLET (EXTENDED-RELEASE)
17 26TABLET, EXTENDED RELEASE;ORAL
18 35TABLET;ORAL
19 3TABLETT
01 67DISCN
02 2Generic
03 4Originator
04 8Prescription
05 46RX
06 23Blank
01 1APO-VERAP TAB 80MG
02 1APO-VERAP TABLET 120MG
03 5CALAN
04 3CALAN SR
05 2COVERA-HS
06 4ISOPTIN
07 1ISOPTIN SR
08 1Isoptin
09 2Isoptin RR retard
10 3Isoptin retard
11 3MYLAN-VERAPAMIL SR
12 1PMS-VERAPAMIL SR
13 3Tarka
14 2Tarka 180/2
15 2Tarka 240/4
16 1VERAPAMIL HCL
17 92VERAPAMIL HYDROCHLORIDE
18 1VERAPAMIL HYDROCHLORIDE INJECTION USP
19 4VERELAN
20 3VERELAN PM
21 1Verahexal 240 Sr
22 4Verapamil Mylan
23 10Blank
01 8Canada
02 9India
03 6South Africa
04 4Sweden
05 8Switzerland
06 1Turkey
07 114USA
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Capsule
Dosage Strength : 120MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : RX
Registration Country : USA
Brand Name : VERAPAMIL HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 120MG
Packaging :
Approval Date : 1999-05-25
Application Number : 75072
Regulatory Info : RX
Registration Country : USA
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Capsule
Dosage Strength : 180MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Capsule
Dosage Strength : 240MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Capsule
Dosage Strength : 360MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : RX
Registration Country : USA
Brand Name : VERAPAMIL HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 240MG
Packaging :
Approval Date : 1999-05-25
Application Number : 75072
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VERAPAMIL HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/2ML (2.5MG/ML)
Packaging :
Approval Date : 1984-03-30
Application Number : 18925
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VERAPAMIL HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/4ML (2.5MG/ML)
Packaging :
Approval Date : 2018-04-05
Application Number : 18925
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date : 1984-03-30
Application Number : 19038
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1984-09-10
Application Number : 18817
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : TABLET;ORAL
Dosage Strength : 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1984-09-10
Application Number : 18817
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1988-02-23
Application Number : 18817
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : TABLET;ORAL
Dosage Strength : 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1988-02-23
Application Number : 18817
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN SR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1986-12-16
Application Number : 19152
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN SR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1989-12-15
Application Number : 19152
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN SR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1991-03-06
Application Number : 19152
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ISOPTIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 18485
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ISOPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-03-08
Application Number : 18593
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ISOPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-03-08
Application Number : 18593
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ISOPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1987-11-23
Application Number : 18593
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
